01 Adoption of Robotic-Assisted Interventional Radiology The need for greater procedural precision and improved operator ergonomics is supporting the adoption of robotic platforms in interventional radiology. The FDA has cleared robotic systems such as the corpath GRX for remote-controlled manipulation of guidewires and catheters during vascular procedures, demonstrating the transition toward robot-assisted endovascular intervention. This technology can improve catheter control and reduce direct radiation exposure for clinicians while supporting complex minimally invasive procedures.
02 Development of Image-Guided Minimally Invasive Procedures The demand for procedures that reduce surgical trauma, recovery time, and hospital stays is driving wider use of real-time imaging to guide minimally invasive interventions. The Society of Interventional Radiology notes that image-guided procedures can use technologies such as ultrasound, CT, MRI, and fluoroscopy to precisely guide instruments through small incisions or needle punctures. This approach can expand minimally invasive treatment options while reducing the need for conventional open surgery in selected clinical applications.
01 Robotic Assistance and Image-Guided Procedures Drive Market The need for greater procedural control creates demand for robotic systems that assist physicians with precise catheter and guidewire navigation during complex vascular interventions. FDA records show that the LIBERTY endovascular robotic system received 510(k) clearance in september 2025, demonstrating the regulatory availability of robotic catheter-control technology for cardiovascular applications. For example, robotic catheter systems can support navigation through peripheral blood vessels while allowing physicians to control device movement from a workstation. This technology availability supports hospital investment in robotic platforms and creates demand for compatible catheters, guidewires, and control components.The need for targeted treatment with limited tissue disruption creates demand for image-guided interventional procedures across vascular, oncological, and other clinical applications. The society of interventional radiology describes interventional radiology as a specialty focused on minimally invasive, image-guided therapies designed to improve patient care. For example, image guidance can support procedures such as tumor ablation, embolization, and percutaneous biopsy by helping physicians identify and reach specific anatomical targets. This clinical approach supports procurement of imaging systems, navigation equipment, needles, catheters, guidewires, and other interventional devices.
01 Healthcare Infrastructure and Operating Costs Restrain Market Expansion Limited access to advanced healthcare infrastructure can restrict the availability of imaging systems, catheterization facilities, specialized procedure rooms, and supporting diagnostic services required for interventional radiology. WHO notes that major gaps remain in access to diagnostic services and essential medical technologies, particularly in low- and middle-income countries. These infrastructure gaps can reduce procedure availability and slow the adoption of interventional radiology technologies.High maintenance and operating costs can arise from regular servicing, calibration, software upgrades, and technical support required for advanced imaging and interventional equipment. WHO highlights that the availability of medical equipment also depends on adequate maintenance systems, technical expertise, spare parts, and financial resources to keep devices functional. These recurring requirements can increase healthcare facility expenses and limit equipment upgrades, restricting market growth.
01 Hospital Partnerships and Specialized Vascular Intervention Devices Offers Growth Opportunities Medical device manufacturers, hospitals, and interventional radiology centers can collaborate on equipment supply, clinical training, and procedure support. Siemens healthineers reported €23.4 billion in revenue for fiscal 2025, with its imaging segment including interventional imaging systems, creating revenue through equipment sales, service contracts, and institutional partnerships.Device manufacturers and vascular specialists can develop specialized catheters, guidewires, stents, and embolization products for complex vascular procedures. Medtronic reported $33.5 billion in fiscal 2025 revenue and maintains a dedicated Peripheral Interventions portfolio, creating revenue through specialized device sales and recurring hospital procurement.
01 Training Requirements and Device Integration Hinders Growth Advanced image-guided procedures require extensive hands-on training and experience before clinicians can perform them efficiently. Specialized training in procedural and imaging skills increases training and proctoring needs when hospitals introduce newer technologies. These learning requirements can slow the adoption of innovative interventional radiology technologies and delay their integration into routine clinical practice.Interventional radiology procedures often combine catheters, guidewires, imaging systems, navigation tools, embolization devices, and other specialized technologies. Differences in device interfaces, compatibility, and clinical workflows can increase procedure-planning and evaluation requirements. Such complexity can make technology adoption more difficult for hospitals and increase the implementation burden for device manufacturers.
June 2026 Siemens Healthineers expanded its interventional radiology portfolio with advancements in image-guided therapy systems and angiography solutions. The technologies support minimally invasive procedures through improved imaging quality, workflow efficiency, and clinical precision.
March 2026 Philips expanded its image-guided therapy platform with enhanced interventional radiology solutions. The developments support advanced catheter-based procedures, real-time imaging, and improved treatment planning for complex interventions.
January 2026 GE HealthCare expanded its interventional imaging portfolio with upgraded angiography and image-guided systems. The solutions support physicians in performing minimally invasive procedures with improved visualization and workflow integration.
October 2025 Boston Scientific expanded its interventional radiology device portfolio with new catheter-based technologies and minimally invasive treatment solutions. The company focused on improving outcomes in vascular and oncology-related interventions.